Beaton Management Co. Inc. Eli Lilly & CO Transaction History

Beaton Management Co. Inc.

$198 Million
Q3 2024

A detailed history of Beaton Management Co. Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Beaton Management Co. Inc. holds 5,747 shares of LLY stock, worth $4.41 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares

5,747

Previous 5,732 0.26%

Holding current value

$4.41 Million

Previous $5.19 Million 1.91%

% of portfolio

2.58%

Previous 2.79%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$772.14 - $960.02 $11,582 - $14,400	15 Added 0.26%	5,747 $5.09 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $3,624 - $4,545	5 Added 0.09%	5,732 $5.19 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $15,989 - $21,391	27 Added 0.47%	5,727 $4.46 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $2.99 Million - $3.53 Million	5,700 New	5,700 $3.32 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $1.35 Million - $1.59 Million	-4,858 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$224.85 - $279.04 $19,112 - $23,718	-85 Reduced 1.72%	4,858 $1.34 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $81,247 - $105,093	450 Added 10.02%	4,943 $1.14 Million
Q3 2019 Nov 15, 2019	BUY	$106.79 - $116.16 $69,413 - $75,504	650 Added 16.91%	4,493 $502,000
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $10,590 - $11,864	-100 Reduced 2.54%	3,843 $445,000
Q3 2018 Nov 16, 2018	BUY	$85.86 - $107.31 $15,884 - $19,852	185 Added 4.92%	3,943 $423,000
Q3 2017 Nov 09, 2017	SELL	$77.07 - $85.54 $7,706 - $8,554	-100 Reduced 2.59%	3,758 $321,000
Q2 2017 Aug 17, 2017	BUY	N/A	3,858	3,858 $318,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaton Management Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beaton Management Co. Inc. with notifications on news.

Account

Beaton Management Co. Inc. Eli Lilly & CO Transaction History